Complement and circulating immune complexes in children with mumps meningitis

Insights

Complement activity (CH50) decreases and circulating immune complexes (CIC) are present in children with mumps meningitis. These levels normalize over time, indicating the immune system

Area of Science:

  • Immunology
  • Virology
  • Pediatrics

Background:

  • Mumps meningitis is a significant neurological complication in children.
  • The role of complement system activation and immune complex formation in mumps meningitis pathogenesis requires further elucidation.

Purpose of the Study:

  • To investigate the dynamics of hemolytic activity of complement (CH50) and the prevalence of circulating immune complexes (CIC) in children diagnosed with mumps meningitis.
  • To characterize the molecular weight and antibody classes within detected immune complexes.

Main Methods:

  • Serum samples were collected from children with mumps meningitis at multiple time points.
  • Hemolytic complement activity (CH50) was measured using standard assays.
  • Circulating immune complexes (CIC) were detected and quantified; high concentration CIC samples were analyzed for molecular weight using sepharose 6B gel filtration and antibody classes (IgG, IgA, IgM) via Elisa.

Main Results:

  • A significant decrease in CH50 levels was observed in 60% of samples during the acute phase (1-6 days), with improvement by the third examination (12-14 months).
  • CIC were present in 21% of samples during the acute phase, decreasing to 14% by the third examination.
  • Analysis of a high CIC sample revealed immune complexes with molecular weights of 2.5 X 10(6) and 5.0 X 10(5) daltons, containing anti-mumps antibodies across IgG, IgA, and IgM classes.

Conclusions:

  • Mumps meningitis is associated with transient complement system activation and the formation of circulating immune complexes.
  • The presence and characteristics of CIC suggest their involvement in the inflammatory process of mumps meningitis.
  • Immune complexes in mumps meningitis contain specific anti-mumps antibodies, highlighting the adaptive immune response.

Related Concept Videos

Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...